Wednesday, March 19, 2025 5:01:19 PM
Let’s take a simple (pretend) example.
In my opinion.
Because of spoofing price per share suppression, in 2019 LP has to sell 20 million instead of ten million shares to keep NWBO afloat.
Let’s say that dilutes the share price by that time period by x%
Now, let’s say NWBO wins their case years later, but, by that time, the pps is not .25 but 25.00.
To calculate the loss of profit, the pps 25.00 would need to be reimbursed by the x percent previously diluted.
Additionally, Multiply that loss by 1 to four times for punitive damages, and the loss of profit plus punitive damages per share gets higher.
In other words, it does not behoove NWBO to keep their price per share low as we now go forward should the court/jury eventually find long term impact on pps from the actions that occurred in years prior.
(Should defendants now try to continue price manipulation, NWBO would best be protected by an injunction, and additional lawsuits, not by keeping their price low)
I think NWBO has to do everything legally and ethically possible upon any approval to improve their share price and availability of treatment to patients.
In my opinion.
Because of spoofing price per share suppression, in 2019 LP has to sell 20 million instead of ten million shares to keep NWBO afloat.
Let’s say that dilutes the share price by that time period by x%
Now, let’s say NWBO wins their case years later, but, by that time, the pps is not .25 but 25.00.
To calculate the loss of profit, the pps 25.00 would need to be reimbursed by the x percent previously diluted.
Additionally, Multiply that loss by 1 to four times for punitive damages, and the loss of profit plus punitive damages per share gets higher.
In other words, it does not behoove NWBO to keep their price per share low as we now go forward should the court/jury eventually find long term impact on pps from the actions that occurred in years prior.
(Should defendants now try to continue price manipulation, NWBO would best be protected by an injunction, and additional lawsuits, not by keeping their price low)
I think NWBO has to do everything legally and ethically possible upon any approval to improve their share price and availability of treatment to patients.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
